BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16787878)

  • 21. Recurrent endobronchial diffuse large B-cell lymphoma. Diagnosed by cryoprobe.
    Pajares V; Torrego A; Granell M; Szafranska J; Mozos A; Puzo C
    Arch Bronconeumol; 2013 May; 49(5):210-2. PubMed ID: 22981515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.
    Gutierrez A; Rodriguez J
    Ann Oncol; 2008 Aug; 19(8):1512. PubMed ID: 18662957
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case].
    Zhang F; Liu YH; Zhuang HG; Li L; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):414-5. PubMed ID: 21055162
    [No Abstract]   [Full Text] [Related]  

  • 25. The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
    García-Sanz R; González-López TJ; Vázquez L; Hermida G; Graciani IF; San Miguel JF
    Eur J Haematol; 2010 Mar; 84(3):266-70. PubMed ID: 19912314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
    Williams KM; Higman MA; Chen AR; Schwartz CL; Wharam M; Colombani P; Arceci RJ
    Pediatr Blood Cancer; 2008 Mar; 50(3):667-70. PubMed ID: 17318876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of the PET-CT in the evaluation of early response to treatment in the diffuse large B-cell lymphoma. Preliminary results.
    Cortés Romera M; Gámez Cenzano C; Caresia Aróztegui AP; Martín-Comín J; González-Barca E; Ricart Brulles Y; Palacios Abufón A; Robles Barba J; Rodríguez-Bel L; Rossi Seoane S; Fernández de Sevilla A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):135-41. PubMed ID: 21944191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite Lymphoma as Co-occurrence of Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Carrying Trisomy 12 and t(14;18) and Peripheral T-cell Lymphoma.
    Aoyama Y; Kodaka T; Zushi Y; Goto Y; Tsunemine H; Itoh T; Takahashi T
    J Clin Exp Hematop; 2018 Mar; 58(1):27-31. PubMed ID: 29415977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
    Tsimberidou AM; McLaughlin P; Younes A; Rodriguez MA; Hagemeister FB; Sarris A; Romaguera J; Hess M; Smith TL; Yang Y; Ayala A; Preti A; Lee MS; Cabanillas F
    Blood; 2002 Dec; 100(13):4351-7. PubMed ID: 12393618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
    Gabarre J; Leblond V; Sutton L; Azar N; Jouan M; Boccaccio C; Gonzalez H; Charlotte F; Gentilini M; Binet JL
    Bone Marrow Transplant; 1996 Dec; 18(6):1195-7. PubMed ID: 8971396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
    Martín A; Redondo AM; Dlouhy I; Salar A; González-Barca E; Canales M; Montes-Moreno S; Ocio EM; López-Guillermo A; Caballero D;
    Br J Haematol; 2016 Apr; 173(2):245-52. PubMed ID: 26847165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
    Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar S; Maghfoor I
    N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
    [No Abstract]   [Full Text] [Related]  

  • 38. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.
    Murohashi I; Kashimura T; Tominaga K; Wakao D; Takahashi T; Akiba M; Kishimoto K; Yoshida K; Yagasaki F; Itoh Y; Sakata T; Kawai N; Itoh K; Suzuki T; Matsuda A; Hirashima K; Bessho M
    Leuk Res; 2002 Mar; 26(3):229-34. PubMed ID: 11792410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
    Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G
    Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.